Search research articles
Contact Us
Filters
Showing results (431-440 of 517) with videos related to
Page
of 52
Sort By:
Cancer Research
|
June 3, 2009
The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase
Christina L Costantino, Agnieszka K Witkiewicz, Yuki Kuwano, et al.
Preventing Chronic Disease
|
June 21, 2005
An innovative approach to enhancing the surveillance capacity of state-based diabetes prevention and control programs: the Diabetes Indicators and Data Sources Internet Tool (DIDIT)
Qaiser Mukhtar, Erica R Brody, Prachi Mehta, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
March 19, 2026
Impaired Adipose Anabolism in Pancreatic Cancer Cachexia Is Reversed by HuR Inhibition
Paige C Arneson-Wissink, Katherine Pelz, Beth Worley, et al.
BMJ Open
|
October 17, 2023
Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma
Francesca M Ponzini, Christopher W Schultz, Benjamin E Leiby, et al.
Journal of the American College of Surgeons
|
February 10, 2018
A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2
Avinoam Nevler, Alexander J Muller, Joseph A Cozzitorto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 28, 2022
Psychosocial distress is dynamic across the spectrum of cancer care and requires longitudinal screening for patient-centered care
Thomas L Sutton, Marina Affi Koprowski, Alison Grossblatt-Wait, et al.
Cancer Research
|
February 28, 2016
Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth
Yu-Hung Huang, Weidan Peng, Narumi Furuuchi, et al.
The Journal of Biological Chemistry
|
April 13, 2012
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized
Christopher C Valley, Andrew K Lewis, Deepti J Mudaliar, et al.
Expert Opinion on Drug Delivery
|
March 6, 2010
Identifying pancreatic cancer patients for targeted treatment: the challenges and limitations of the current selection process and vision for the future
Shayna L Showalter, Sarah Charles, Justin Belin, et al.
Journal of Pancreatic Cancer
|
May 9, 2019
A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Anteneh A Tesfaye, Hongkun Wang, Marion L Hartley, et al.
Page
of 52
Search research articles
Search
Showing results (431-440 of 517) with videos related to
Sort By:
Page
of 52
Cancer Research
|
June 3, 2009
The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase
Christina L Costantino, Agnieszka K Witkiewicz, Yuki Kuwano, et al.
Preventing Chronic Disease
|
June 21, 2005
An innovative approach to enhancing the surveillance capacity of state-based diabetes prevention and control programs: the Diabetes Indicators and Data Sources Internet Tool (DIDIT)
Qaiser Mukhtar, Erica R Brody, Prachi Mehta, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
March 19, 2026
Impaired Adipose Anabolism in Pancreatic Cancer Cachexia Is Reversed by HuR Inhibition
Paige C Arneson-Wissink, Katherine Pelz, Beth Worley, et al.
BMJ Open
|
October 17, 2023
Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma
Francesca M Ponzini, Christopher W Schultz, Benjamin E Leiby, et al.
Journal of the American College of Surgeons
|
February 10, 2018
A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2
Avinoam Nevler, Alexander J Muller, Joseph A Cozzitorto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 28, 2022
Psychosocial distress is dynamic across the spectrum of cancer care and requires longitudinal screening for patient-centered care
Thomas L Sutton, Marina Affi Koprowski, Alison Grossblatt-Wait, et al.
Cancer Research
|
February 28, 2016
Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth
Yu-Hung Huang, Weidan Peng, Narumi Furuuchi, et al.
The Journal of Biological Chemistry
|
April 13, 2012
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized
Christopher C Valley, Andrew K Lewis, Deepti J Mudaliar, et al.
Expert Opinion on Drug Delivery
|
March 6, 2010
Identifying pancreatic cancer patients for targeted treatment: the challenges and limitations of the current selection process and vision for the future
Shayna L Showalter, Sarah Charles, Justin Belin, et al.
Journal of Pancreatic Cancer
|
May 9, 2019
A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Anteneh A Tesfaye, Hongkun Wang, Marion L Hartley, et al.
Page
of 52